SCHEMBL7704769

SCHEMBL7704769

O=C(N[C@@H](Cc1ccccc1)C(=O)CNS(=O)(=O)c1ccccc1)c1ccc(SCc2ccc3ccccc3c2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 3/20 0.52
ITGB1 P05556 1/20 0.44
ITGA4 P13612 1/20 0.44
CTSL P07711 1/20 0.44
CTSB P07858 1/20 0.44
CTSS P25774 1/20 0.44
CTSK P43235 1/20 0.44
CA1 P00915 2/20 0.43
KAT6A Q92794 1/20 0.42
CASP1 P29466 1/20 0.41
ACE P12821 2/20 0.41
PTPN1 P18031 1/20 0.40
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
KMT2A Q03164 1/20 0.39
OPRD1 P41143 1/20 0.39
OPRK1 P41145 1/20 0.39
PLAT P00750 1/20 0.39
MCL1 Q07820 1/20 0.39
BCL2A1 Q16548 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7701294 0.90 CA2 (0.50) CA2ITGB1ITGA4CTSLCTSB
SCHEMBL7686484 0.88 CA2 (0.44) CA2ITGB1ITGA4CTSLCTSB
SCHEMBL7694676 0.86 CTSL (0.49) CA2CTSLCTSBCTSSCTSK
SCHEMBL7701695 0.85 CA2 (0.52) CA2ITGB1ITGA4CASP1ACE
SCHEMBL7696723 0.84 CTSS (0.50) CA2CTSLCTSBCTSSCTSK
SCHEMBL7700700 0.83 CA2 (0.52) CA2ITGB1ITGA4CTSLCTSB
SCHEMBL7703565 0.82 CA2 (0.51) CA2CA1KAT6AALDH1A1OPRD1
SCHEMBL7701518 0.78 CA2 (0.44) CA2ITGB1ITGA4CTSLCTSB
SCHEMBL7682464 0.78 CA2 (0.42) CA2CTSLCTSBCTSSCTSK
SCHEMBL7692550 0.77 AKR1C3 (0.51) CA2KAT6AMEN1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6436925-B1 BETTER ABLE TO CROSS MEMBRANES; INHIBITORS OF CYSTEINE PROTEASES LIKE CALPAIN I AND II AND CATHEPSIN B AND L, CAN THUS BE USED TO CONTROL DISEASES ASSOCIATED WITH AN ELEVATED ACTIVITY OF CALPAIN ENZYMES OR CATHEPSIN ENZYMES ABBOTT LABORATORIES 2002-08-20 US disclosed